Skip to main content
. 2020 Oct 9;2020:3580719. doi: 10.1155/2020/3580719

Figure 1.

Figure 1

NFE2L2 is abnormally expressed in pan-cancer. (a) NFE2L2 expression in 31 normal tissues from the GTEx database. (b) NFE2L2 expression in 21 tumor cells from the CCLE database. (c) Differential expression of NFE2L2 in cancers and normal tissues from TCGA database. (d) NFE2L2 expression in 27 cancer types from the GTEx database and TCGA database (P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001).